INTRODUCTION
============

Obesity significantly increases the risk of colorectal cancer (CRC) \[[@b1-ir-2018-00072],[@b2-ir-2018-00072]\]. However, the underlying mechanisms are still unclear. Insulin resistance and altered levels of adipocytokines might have a role in obesity-induced colorectal carcinogenesis \[[@b2-ir-2018-00072]\]. Insulin resistance increases the risk of CRC, and insulinlike growth factor-1 seems to have a key role in the relationship between insulin resistance and CRC \[[@b3-ir-2018-00072]\]. Obesity can directly cause chronic mild inflammation of the colonic mucosae from increased TNF-α and interleukin-6 and decreased adiponectin \[[@b4-ir-2018-00072]\].

Although BMI and waist circumference (WC) have traditionally been used as proxies for obesity, recent studies have suggested that abdominal visceral adipose tissue (VAT) area measured by CT might be a better indicator than BMI or WC for the risk of developing colorectal neoplasm \[[@b5-ir-2018-00072]-[@b7-ir-2018-00072]\]. Abdominal adipose tissue consists of subcutaneous adipose tissue (SAT) and VAT. An increase in VAT leads to insulin resistance and deregulated secretion of proinflammatory cytokines and adipokines, which are presumed to have a role in the development of colorectal neoplasm \[[@b5-ir-2018-00072],[@b8-ir-2018-00072]\]. Several studies have shown that visceral adiposity is a risk factor for colorectal adenoma. However, previous results on the association of VAT with the risk of CRC have been inconsistent \[[@b9-ir-2018-00072]-[@b11-ir-2018-00072]\].

In Korea, CRC is the second most diagnosed cancer in men, and the third in women \[[@b12-ir-2018-00072]\]. The proportion of overweight and obese individuals increased in 1998 to 2009, especially among men \[[@b13-ir-2018-00072]\]. From this background, we examined whether visceral adiposity serves as a risk factor for CRC and colorectal adenomas in the Korean population. In addition, we assessed the changes of VAT and SAT areas in a subset of CRC patients in the years before the diagnosis of CRC.

METHODS
=======

1. Study Subjects
-----------------

This was a retrospective case-control study. We enrolled the study subjects from January 2011 to December 2015 at Seoul National University Bundang Hospital. They included 151 patients with CRC, 200 patients with colorectal adenoma, and 200 healthy individuals (control group). Patients with adenoma and controls were age- and gender-matched (1:1 or 1:2 matching) with CRC patients. All the study subjects received a colonoscopy at the time of enrollment, and they all had a CT scan available for abdominal fat measurement. We excluded individuals who had suspicious hereditary CRC (i.e., familial adenomatous polyposis or hereditary non-polyposis CRC), IBD, or previous history of any cancer. We also excluded those who had significant abnormal findings including liver cirrhosis, intra-abdominal abscess, or severe inflammation on abdominal CT.

All subjects in the control and adenoma groups underwent laboratory tests, colonoscopic examination, and abdominal CT scan on the same day during a routine health check-up at Seoul National University Bundang Hospital Health Promotion Center. If the patient had no previous history of colorectal adenoma and colonoscopy showed no evidence of colorectal adenomatous polyps, the patient was classified into the control group. If colonoscopy had one or more adenomatous polyps, they were classified into the adenoma group. Patients in the CRC group were newly diagnosed with primary CRC which was pathologically confirmed at the time of enrollment. The CRC group included 46 patients with early-stage cancer (stage I) and 105 with advanced-stage cancer (stage II-IV). Among these 151 patients, 42 (17 with early-stage and 25 with advancedstage cancer) also had an abdominal CT scan available for abdominal fat measurement taken 1 to 4 years before the diagnosis of CRC (mean±SD of CT interval, 20.6 ± 9.4 months) as a routine health check-up. Of these 42 patients, none had previous CT scans showing evidence of liver cirrhosis, tumor, abscess, or severe inflammation. The study protocol was approved by the Institutional Review Board of Seoul National University Hospital (IRB No. B-1511/324-111). The informed consent was waived.

2. Clinical and Laboratory Evaluations
--------------------------------------

A retrospective review of electronic medical records was conducted to evaluate age, gender, height, weight, WC, personal medical history, familial cancer history, and laboratory data. Venous sampling was performed after overnight fasting. The laboratory tests included total cholesterol and fasting glucose levels.

3. Colonoscopic Examination
---------------------------

Expert endoscopists performed colonoscopy with an electric video endoscope (model CF260; Olympus Optical, Tokyo, Japan). Adequate bowel preparation was confirmed by a Boston Bowel Preparation Score of ≥2 in all three segments \[[@b14-ir-2018-00072]\]. Small polyps (\< 5 mm in diameter) were removed by biopsy. Large polyps (≥ 1 cm in diameter) were removed by polypectomy or endoscopic mucosal resection. Polyps were fixed in formaldehyde and evaluated histologically according to the World Health Organization criteria. Adenomas were recorded according to the location, size, and number of polyps. Hyperplastic polyps were excluded. Advanced adenoma was defined as adenoma ≥ 1 cm in diameter, ≥3 adenomatous polyps, high-grade dysplasia, or adenoma containing \>25% villous components. Early-stage CRC was defined to be stage I cancer. Cancer staging was performed according to the criteria of the American Joint Committee on Cancer, 7th version \[[@b15-ir-2018-00072]\]; T1N0M0 and T2N0M0 were classified as stage I cancer.

4. Measurement of Abdominal Adipose Tissue
------------------------------------------

All subjects underwent abdominal CT using a 16 or 64-detector row CT scanner (Mx8000 IDT 16 and Brilliance 64; Philips Medical Systems, Cleveland, OH, USA). The SAT and VAT areas (cm^2^) were measured by a dedicated offline workstation (Aquarius 3D Workstation; TeraRecon Inc., San Mateo, CA, USA) using a mean of 3 serial slice at the umbilicus level \[[@b16-ir-2018-00072],[@b17-ir-2018-00072]\]. We predefined the adipose tissues of the software between --195 and --45 Hounsfield Units (HU), which is an adequate range of adipose tissue on CT images \[[@b16-ir-2018-00072],[@b18-ir-2018-00072]\]. Abdominal adipose tissue is divided into 2 compartments, SAT and VAT, by the parietal peritoneum. VAT is the adipose tissue inside the parietal peritoneum, excluding the paraspinal muscles and the vertebral column. SAT is the adipose tissue outside the parietal peritoneum, including the abdominal and back muscles.

5. Statistical Analyses
-----------------------

Categorical variables are presented as number and percentage, and continuous variables are presented as mean±SD. The data were appropriately analyzed using chi-square test, ANOVA with *post hoc* Tukey honest significant difference (HSD) test, paired *t*-test, or multivariate logistic regression. An unconditional logistic regression model was applied to estimate the association between abdominal adipose tissue areas and the risks of colorectal adenoma and CRC, and was adjusted for age, gender, smoking, education level, and familial history of CRC. Differences were considered significant when *P*-values were \<0.05. All analyses were performed using SPSS version 22.0 (IBM Corp., Armonk, NY, USA).

RESULTS
=======

1. Characteristics of the Study Subjects
----------------------------------------

[Table 1](#t1-ir-2018-00072){ref-type="table"} shows the baseline characteristics of the study subjects. The adenoma group had a significantly increased body weight, BMI, WC, VAT area, total fat area, and visceral-to-total fat ratio compared with the control group (all *P*\< 0.05 by ANOVA *post hoc* analysis using Tukey HSD test.) The means ±SD of the VAT areas were 94.6 ± 46.6 cm^2^ in the control group, 116.8 ± 49.5 cm^2^ in adenoma group, 110.4 ± 56.8 cm^2^ in the early-stage CRC group, and 99.7 ±49.3 cm^2^ in the advanced-stage CRC group (*P*\<0.004 by ANOVA). SAT areas were not different among the 4 groups (*P*\>0.05).

In contrast, fasting plasma glucose levels were significantly higher in the CRC groups (mean±SD, 106.5 ± 37.6 mg/dL and 107.1±21.2 mg/dL in the early- and advanced-stage CRC groups, respectively) than in the control group (92.8 ± 20.0 mg/dL, *P*\<0.01), and serum total cholesterol levels were significantly lower in the CRC groups (180.3 ± 35.1 mg/dL and 173.1 ± 36.3 mg/dL in the early- and advanced-stage CRC groups, respectively) than in the control group (200.0±35.3 mg/dL, *P*\<0.01) ([Table 1](#t1-ir-2018-00072){ref-type="table"}).

2. The Risk of Colorectal Adenoma and CRC by Adipose Tissue Area and Fasting Plasma Glucose Level
-------------------------------------------------------------------------------------------------

Next, we analyzed whether the SAT area VAT area, and the visceral-to-total fat ratio were risk factors of CRC or adenoma using quartile categories of these variables by logistic regression analysis models. We found that the risk of colorectal adenoma positively correlated not only with the VAT area but also the visceral-to-total fat ratio (*P* for trend \<0.01) ([Table 2](#t2-ir-2018-00072){ref-type="table"}). However, there was no association of the SAT area with the risk of adenoma (*P*\>0.05). In addition, there was no trend found with regard to the association between these variables and the risk of CRC (*P*\>0.05).

Moreover, the risk of adenoma increased with increases of body weight, BMI, and WC (*P* for trend \<0.05), but that of CRC did not (*P*\>0.05) ([Table 3](#t3-ir-2018-00072){ref-type="table"}). Interestingly, not only the risk of adenoma but also that of CRC significantly increased along with the fasting plasma glucose level (*P* for trend \<0.05).

We also compared the adipose tissue areas from the CT images taken at diagnosis with those from CT images taken 1 to 4 years before the diagnosis of CRC in 42 CRC patients ([Table 4](#t4-ir-2018-00072){ref-type="table"}). In the patients with early-stage CRC (n=17), the VAT areas were decreased at diagnosis, but the SAT areas were unchanged. Thus visceral-to-total fat ratio at diagnosis was significantly lower than that before diagnosis (46.6% vs. 50.7%, *P*=0.018 by paired *t*-test) ([Table 3](#t3-ir-2018-00072){ref-type="table"}). Among patients with advanced-stage CRC (n =25), however, the SAT area and the VAT area were both decreased (all *P*\<0.001), so the ratio for visceral-to-total fat was not different before and at diagnosis.

DISCUSSION
==========

In the present study, visceral obesity was an independent risk factor of colorectal adenoma, along with body weight, BMI, and WC. In contrast, subcutaneous fat was not associated with the risk of adenoma ([Table 2](#t2-ir-2018-00072){ref-type="table"}). Our findings are consistent with the findings of previous studies.

To date, several indicators have been suggested to determine obesity. Among them, both BMI and body weight appear to reflect the amount of whole body fat, whereas WC and waist to hip ratio correspond to visceral fat. In this study, we adopted a technique using CT images to measure the abdominal adipose tissue areas which has been standardized and validated in previous studies \[[@b19-ir-2018-00072],[@b20-ir-2018-00072]\]. The VAT area is regarded as a better indicator for evaluating the risk of CRC by obesity than other anthropometric markers \[[@b21-ir-2018-00072]\].

There has been strong evidence that visceral obesity increases the risk of colorectal adenoma \[[@b5-ir-2018-00072],[@b6-ir-2018-00072],[@b11-ir-2018-00072],[@b22-ir-2018-00072]\]. However, there are limited reports on the association between visceral obesity and CRC, and the results are inconsistent \[[@b10-ir-2018-00072],[@b23-ir-2018-00072]\]. In this study, we found only insignificant results with regard to the association between obesity markers and the risk of CRC ([Tables 2](#t2-ir-2018-00072){ref-type="table"} and [3](#t3-ir-2018-00072){ref-type="table"}). In early-stage CRC, body weight and BMI increased along with the risk of CRC, although it was not statistically significant (*P* for trend \>0.05) ([Table 3](#t3-ir-2018-00072){ref-type="table"}). In advanced-stage CRC, the association of BMI with the risk of CRC showed only marginal significance (*P* for trend=0.066). In both the early- and advancedstage CRC groups, there was no association observed between the SAT and VAT areas and the risk of CRC ([Table 2](#t2-ir-2018-00072){ref-type="table"}).

We speculated that the negative results in the CRC groups might be attributed to the loss of the adipose tissue in the late stages of colorectal carcinogenesis. However, there are other possibilities. In Western population, adenoma-carcinoma sequence is well-established and up to \~90% of CRC cases occurs following this sequence. However, the adenoma-carcinoma sequence in colorectal carcinogenesis might be less dominant in the Asian population. That is, CRC can develop directly from the normal colonic mucosa without undergoing the adenomatous stage in non-obese individuals (*de novo* pathway hypothesis) \[[@b24-ir-2018-00072]\].

To clarify this issue, we compared the CT scans taken at the diagnosis of CRC and those taken 1 to 4 years before diagnosis in a subset of the CRC patients (n=42) ([Table 4](#t4-ir-2018-00072){ref-type="table"}). Interestingly, we found that the abdominal adipose tissue areas significantly decreased in the years prior to CRC. In patients with early-stage CRC, the VAT area had decreased at the early stages of adenoma-carcinoma sequence, whereas the SAT area was unchanged. Therefore, the ratio for visceral-to-total fat significantly decreased ([Table 3](#t3-ir-2018-00072){ref-type="table"}). In advanced-stage CRC patients, however, not only visceral fat but also subcutaneous fat decreased (P-values\<0.001) ([Table 3](#t3-ir-2018-00072){ref-type="table"}).

Our findings are consistent with the findings of previous studies that evaluated changes in the abdominal adipose tissue areas in advanced cancer patients. These studies reported a rapid loss of adipose tissue as cancer progresses \[[@b25-ir-2018-00072]\]. In addition, a recent study performed longitudinal analyses of CT images in patients with advanced gastrointestinal cancers, including CRC, and found that the loss of VAT preceded that of SAT \[[@b26-ir-2018-00072]\]. VAT and SAT differ not only by anatomic location but also by endocrine function, adipokine secretion, lipolytic activity, and the response to insulin \[[@b27-ir-2018-00072]\]. A previous study reported that saturated fatty acids were higher and monounsaturated fatty acids were lower in visceral fat than in subcutaneous fat \[[@b28-ir-2018-00072]\]. VAT has a unique architecture in that it is highly cellular, hypervascular and innervated and it contains various cells with inflammatory and immunological functions \[[@b29-ir-2018-00072]\]. Differential fat loss between VAT and SAT might be related to the production of carcinogenic mediators, which might lead to the progression of colorectal carcinogenesis \[[@b26-ir-2018-00072],[@b30-ir-2018-00072]\].

Based on these previous findings, we hypothesized a new role for VAT in colorectal carcinogenesis. Visceral fat accumulation likely has a role in adenoma formation. However, lipolysis of the visceral fat occurs later, and it may be important in the progression from adenoma to carcinoma. In advancedstage CRC, the loss of subcutaneous fat occurs, which is probably owing to cancer-related cachexia. We acknowledge that our results should be confirmed in large prospective cohort studies including the patients with both colorectal adenoma and CRC. Nevertheless, the differential loss of VAT and SAT in early-stage CRC was remarkable even with the small number of patients included in our study.

In this study, fasting plasma glucose level was significantly increased in both adenoma and CRC groups ([Table 3](#t3-ir-2018-00072){ref-type="table"}). The risk of colorectal adenoma increased along with fasting plasma glucose level (*P* for trend=0.040) ([Table 3](#t3-ir-2018-00072){ref-type="table"}), but the association was more prominent in the early- and advanced-CRC groups (*P* for trend=0.024 and *P* for trend=0.001 in the early- and advanced-CRC groups, respectively.) Our findings of the relationship between serum glucose level and the risk of CRC were consistent with the findings of previous studies \[[@b31-ir-2018-00072]\]. Impaired fasting glucose and/or hyperinsulinemia are considered as risk factors for the development of CRC \[[@b32-ir-2018-00072]\]. Insulin resistance results in hyperinsulinemia which is associated with increased levels of insulin-like growth factor-1, an anti-apoptotic and mitogenic factor \[[@b33-ir-2018-00072]\]. Previous studies have reported that type 2 diabetes is associated with an increased risk of CRC \[[@b34-ir-2018-00072],[@b35-ir-2018-00072]\]. A recent meta-analysis showed an increase of 29% in the risk of CRC among patients with impaired fasting glucose, impaired glucose tolerance, or overt type 2 diabetes mellitus \[[@b36-ir-2018-00072]\].

Serum total cholesterol level showed an insignificant positive correlation with the risk of adenoma (*P* for trend=0.092) ([Table 3](#t3-ir-2018-00072){ref-type="table"}). However, it showed a negative correlation with the risk of CRC (*P* for trend \<0.01). To date, the relationship between dyslipidemia and colorectal adenoma is nebulous \[[@b37-ir-2018-00072]\]. In the case of CRC, the negative correlations may be attributed to cancer-related cachexia.

This study has the following limitations. First, this study was designed to be a retrospective case-control study. The control and adenoma groups were enrolled from the health promotion center, and the CRC groups were enrolled from the gastroenterology and general surgery departments. Thus, there might be selection bias. For example, there was a significant difference observed in education level among the groups ([Table 1](#t1-ir-2018-00072){ref-type="table"}). Second, this study was retrospective, and information on some of the risk factors for CRC, such as red meat consumption and alcohol intake amount, was not available. Third, there were only 42 CRC patients who had CT images available both at and prior to diagnosis. In addition, there was no information available on the endoscopic findings at the time of the CT scan prior to diagnosis, such as the number of colorectal adenomas. This significantly weakens the clinical importance of our novel findings. However, to eliminate any biases, we excluded any patients who had undergone abdominal CT scan for the evaluation of their abdominal symptoms, as well as those who had significant abnormal findings in a previous CT scan that might affect the quantities of abdominal adipose tissues. Fourth, it has been suggested that volumetric measure of VAT might be more accurate than VAT area. However, the technique we used for the measurement of the VAT area has been standardized and validated in previous studies \[[@b19-ir-2018-00072],[@b20-ir-2018-00072]\]. Fifth, data on serum triglycerides, high-density lipoprotein-cholesterol levels, and plasma insulin level were not available, especially in the CRC groups. The associations between serum triglycerides, low- and high-density lipoprotein-cholesterols and the risk of CRC are still inconclusive \[[@b36-ir-2018-00072]\]. Hence, further studies are warranted in this issue.

To conclude, the accumulation of visceral fat is related to the development of colorectal adenoma, but the loss of visceral fat is observed beginning in the early stage of CRC. In contrast, the loss of subcutaneous fat occurs in the advanced stages of CRC. In addition, impaired fasting glucose may have a role in the development of CRC. Further studies are warranted in on this issue.
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###### 

Characteristics of the Study Subjects

  Characteristic                                                      Control (n=200)   Adenoma (n=200)          Early-stage CRC (n=46)^[a](#tfn1-ir-2018-00072){ref-type="table-fn"}^   Advanced-stage CRC (n=105)^[b](#tfn2-ir-2018-00072){ref-type="table-fn"}^   *P*-value^[c](#tfn3-ir-2018-00072){ref-type="table-fn"}^
  ------------------------------------------------------------------- ----------------- ------------------------ ----------------------------------------------------------------------- --------------------------------------------------------------------------- ----------------------------------------------------------
  Age (yr)                                                            55.5±7.8          54.9±7.8                 57.1±10.0                                                               56.3±10.0                                                                   0.311
  Male sex                                                            100 (50.0)        100 (50.0)               23 (50.0)                                                               55 (52.4)                                                                   0.979
  Height (cm)                                                         163.6±8.3         163.8±8.5                161.8±8.5                                                               161.9±7.6                                                                   0.156
  Weight (kg)                                                         62.8±10.9         **65.9±11.4^\*^**        63.4±10.8                                                               63.8±9.4                                                                    **0.040**
  BMI (kg/m^2^)                                                       23.4±3.1          **24.4±3.1^\*^**         24.1±2.6                                                                24.3±3.0                                                                    **0.003**
  Waist circumference (cm)                                            81.6±7.8          **84.1±7.6^\*\*^**       82.6±7.6                                                                83.0±7.0                                                                    **0.016**
  Education                                                                                                                                                                                                                                                          
   Elementary-middle                                                  28 (14.0)         23 (11.5)                15 (32.6)                                                               29 (27.6)                                                                   **\<0.001**
   High                                                               35 (17.5)         51 (25.5)                11 (23.9)                                                               33 (31.4)                                                                   
   University                                                         78 (39.0)         88 (44.0)                17 (37.0)                                                               43 (41.0)                                                                   
   Non-responder                                                      59 (29.5)         38 (19.0)                3 (6.5)                                                                 0                                                                           
  Smoking                                                                                                                                                                                                                                                            
   Current smoker                                                     34 (17.0)         52 (26.0)                15 (32.6)                                                               27 (25.7)                                                                   **\<0.001**
   Ex-smoker                                                          50 (25.0)         26 (13.0)                4 (8.7)                                                                 8 (7.6)                                                                     
   Nonsmoker                                                          116 (58.0)        122 (61.0)               27 (58.7)                                                               70 (66.7)                                                                   
  Comorbidity                                                                                                                                                                                                                                                        
   Hypertension                                                       44 (22.0)         57 (28.5)                13 (28.3)                                                               28 (26.7)                                                                   0.483
   Diabetes                                                           15 (7.5)          23 (11.5)                4 (8.7)                                                                 19 (18.1)                                                                   **0.043**
  Family history of CRC among first-degree relatives                  12 (6.0)          17 (8.5)                 1 (2.2)                                                                 6 (5.7)                                                                     0.406
  Advanced adenomatous polyp                                          \-                48 (24.0)                \-                                                                      \-                                                                          \-
  Right colon cancer^[d](#tfn4-ir-2018-00072){ref-type="table-fn"}^   \-                \-                       10 (21.7)                                                               35 (33.3)                                                                   0.152
  Serum total cholesterol (mg/dL)                                     200.0±35.3        208.9±38.5               **180.3±35.1^\*\*^**                                                    **173.1±36.3^\*\*\*^**                                                      **\<0.001**
  Plasma fasting glucose (mg/dL)                                      92.8±20.0         98.1±26.8                **106.5±37.6^\*\*^**                                                    **107.1±21.2^\*\*\*^**                                                      **\<0.001**
  VAT area (V, cm^2^)                                                 94.6±46.6         **116.8±49.5^\*\*\*^**   110.4±56.8                                                              99.7±49.3                                                                   **\<0.001**
  SAT area (S, cm^2^)                                                 139.7±57.1        151.6±56.3               137.9±49.7                                                              135.7±52.4                                                                  0.051
  Total fat area (V+S, cm^2^)                                         234.3±88.8        **268.4±88.4^\*\*\*^**   248.3±78.9                                                              235.4±80.2                                                                  **\<0.001**
  visceral-to-total fat ratio, V/(V+S)                                39.6±11.3         **43.1±10.8^\*^**        43.3±13.8                                                               41.7±12.8                                                                   **0.018**

Values are presented as the mean±SD or number (%).

Stage I cancers.

Stages II-IV cancers.

*P*-values were calculated using chi-square test (categorical variables) or ANOVA (continuous variables).

Right-sided colon cancer is a cancer derived from the embryologic midgut including the cecum, ascending colon, and transverse colon.

CRC, colorectal cancer; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue; V/(V+S), visceral adipose tissue area/(\[visceral adipose tissue area\]+\[subcutaneous adipose tissue area\]).

^\*^*P*\<0.05, ^\*\*^*P*\<0.01, ^\*\*\*^*P*\<0.001 compared with control group using ANOVA *post hoc* analysis using Turkey honest significant difference test. Differences were considered significant when *P*-values were \<0.05.

###### 

The Association of Adipose Tissue Area with the Risk for Colorectal Adenoma, Early-Stage CRC, and Advance-Stage CRC

                                                                                         Control (n=200) vs. adenoma (n=200)   Control (n=200) vs. early-stage CRC (n=46)^[a](#tfn5-ir-2018-00072){ref-type="table-fn"}^   Control (n=200) vs. advanced-stage CRC (n=105)^[b](#tfn6-ir-2018-00072){ref-type="table-fn"}^                                                                                                                                         
  -------------------------------------------------------------------------------------- ------------------------------------- ------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------- ------------------- --------- ------------------- ------- ------------------- ------- ------------------- ------- ------------------- -------
  SAT area^[e](#tfn9-ir-2018-00072){ref-type="table-fn"}^                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                         Quartile I                            1 (Reference)                                                                                                                                                                               1 (Reference)                 1 (Reference)               1 (Reference)               1 (Reference)               1 (Reference)       
                                                                                         Quartile II                           0.93 (0.53--1.65)                                                                           0.809                                                                                           0.93 (0.51--1.67)   0.799     0.71 (0.29--1.75)   0.463   0.73 (0.28--1.92)   0.522   1.35 (0.71--2.54)   0.360   1.88 (0.89--3.97)   0.097
                                                                                         Quartile III                          1.50 (0.86--2.62)                                                                           0.158                                                                                           1.49 (0.83--2.66)   0.179     1.16 (0.50--2.68)   0.736   1.30 (0.52--3.26)   0.573   1.07 (0.54--2.11)   0.853   1.65 (0.74--3.69)   0.223
                                                                                         Quartile IV                           1.34 (0.78--2.33)                                                                           0.292                                                                                           1.22 (0.69--2.16)   0.491     0.58 (0.22--1.51)   0.265   0.52 (0.19--1.43)   0.205   0.78 (0.39--1.58)   0.496   0.73 (0.33--1.60)   0.427
                                                                                         *P* for trend                                                                                                                     0.132                                                                                                               0.257                         0.490                       0.420                       0.396                       0.399
  VAT area^[f](#tfn10-ir-2018-00072){ref-type="table-fn"}^                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                         Quartile I                            1 (Reference)                                                                                                                                                                               1 (Reference)                 1 (Reference)               1 (Reference)               1 (Reference)               1 (Reference)       
                                                                                         Quartile II                           1.81 (1.02--3.20)                                                                           0.044                                                                                           1.86 (1.03--3.37)   0.041     0.71 (0.26--1.95)   0.504   0.77 (0.26--2.27)   0.635   0.78 (0.41--1.49)   0.456   1.13 (0.54--2.38)   0.748
                                                                                         Quartile III                          1.62 (0.90--2.92)                                                                           0.109                                                                                           1.71 (0.93--3.15)   0.086     1.82 (0.78--4.23)   0.166   1.50 (0.61--3.69)   0.375   0.90 (0.48--1.69)   0.743   0.84 (0.41--1.70)   0.625
                                                                                         Quartile IV                           3.86 (2.14--6.95)                                                                           \<0.001                                                                                         3.90 (2.11--7.20)   \<0.001   1.71 (0.67--4.36)   0.258   1.24 (0.45--3.42)   0.676   1.06 (0.53--2.10)   0.870   0.98 (0.44--2.18)   0.964
                                                                                         *P* for trend                                                                                                                     \<0.001                                                                                                             \<0.001                       0.090                       0.417                       0.887                       0.763
  Visceral-to-total fat ratio, V/(V+S)^[g](#tfn11-ir-2018-00072){ref-type="table-fn"}^                                                                                                                                                                                                                                                                                                                                                                           
                                                                                         Quartile I                            1 (Reference)                                                                                                                                                                               1 (Reference)                 1 (Reference)               1 (Reference)               1 (Reference)               1 (Reference)       
                                                                                         Quartile II                           1.23 (0.70--2.16)                                                                           0.466                                                                                           1.17 (0.65--2.10)   0.610     0.52 (0.18--1.49)   0.224   0.49 (0.16--1.49)   0.210   0.65 (0.34--1.26)   0.201   0.74 (0.35--1.56)   0.425
                                                                                         Quartile III                          1.94 (1.09--3.44)                                                                           0.025                                                                                           1.86 (1.02--3.39)   0.043     1.93 (0.81--4.57)   0.136   1.40 (0.55--3.57)   0.479   1.04 (0.54--2.00)   0.917   1.00 (0.48--2.10)   0.999
                                                                                         Quartile IV                           2.35 (1.32--4.17)                                                                           0.004                                                                                           2.51 (1.37--4.60)   0.003     1.68 (0.69--4.14)   0.256   1.25 (0.47--3.32)   0.657   1.16 (0.60--2.23)   0.662   1.16 (0.53--2.54)   0.705
                                                                                         *P* for trend                                                                                                                     0.001                                                                                                               0.001                         0.059                       0.309                       0.464                       0.616

Stage I colorectal cancers.

Stages II-IV colorectal cancers.

Unadjusetd model.

Adjusted for gender, age, smoking, education, and the family history of colorectal cancer.

Quartile I represents M\<91.3 cm^2^ and F\<124.3 cm^2^; quartile II represents M 91.3--121.3 cm^2^, F 124.3--155.7 cm^2^; quartile III represents M 121.3--147.8 cm^2^, F 155.7--198.2 cm^2^; quartile IV represents M≥147.8 cm^2^, F≥198.2 cm^2^.

Quartile I represents M\<83.8 cm^2^ and F\<56.5 cm^2^; quartile II represents M 83.8--120.7 cm^2^, F 56.5--84.6 cm^2^; quartile III represents M 120.7--157.7 cm^2^, F 84.6--110.5 cm^2^; quartile IV represents M≥157.8 cm^2^, F≥110.5 cm^2^.

Quartile I represents M\<43.4% and F\<27.8%; quartile II represents M 43.4%--50.2%, F 27.8%--33.5%; quartile III represents M 50.2%--54.6%, F 33.5%--40.8%; quartile IV represents M≥54.6%, F≥40.8%.

CRC, colorectal cancer; aOR, adjusted OR; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; V/(V+S), visceral adipose tissue area/(\[visceral adipose tissue area\]+\[subcutaneous adipose tissue area\]); M, male; F, female.

Differences were considered significant when *P*-values were \<0.05.

###### 

The Association of Anthropometric Findings, the Levels of Plasma Fasting Glucose, and Serum Total Cholesterol with the Risk of Colorectal Adenoma, Early-Stage CRC, and Advance-Stage CRC

                                                                                  Control (n=200) vs. adenoma (n=200)   Control (n=200) vs. early-stage CRC (n=46)^[a](#tfn12-ir-2018-00072){ref-type="table-fn"}^   Control (n=200) vs. advanced-stage CRC (n=105)^[b](#tfn13-ir-2018-00072){ref-type="table-fn"}^                                                                                                                                               
  ------------------------------------------------------------------------------- ------------------------------------- -------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ------------------- --------- -------------------- ------- -------------------- ------- -------------------- --------- -------------------- ---------
  Body weight^[e](#tfn16-ir-2018-00072){ref-type="table-fn"}^                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                  Quartile I                            1 (Reference)                                                                                                                                                                                 1 (Reference)                 1 (Reference)                1 (Reference)                1 (Reference)                  1 (Reference)        
                                                                                  Quartile II                           1.60 (0.92--2.80)                                                                            0.099                                                                                            1.79 (1.00--3.22)   0.051     0.77 (0.28--2.09)    0.602   0.97 (0.33--2.86)    0.952   1.94 (0.99--3.78)    0.053     2.94 (1.34--6.46)    0.007
                                                                                  Quartile III                          1.31 (0.74--2.33)                                                                            0.362                                                                                            1.36 (0.75--2.47)   0.317     2.01 (0.88--4.58)    0.096   2.56 (1.02--6.41)    0.045   2.23 (1.16--4.32)    0.017     3.10 (1.45--6.62)    0.004
                                                                                  Quartile IV                           2.52 (1.46--4.37)                                                                            0.001                                                                                            2.50 (1.41--4.44)   0.002     1.13 (0.44--2.90)    0.808   1.30 (0.47--3.64)    0.614   1.29 (0.61--2.70)    0.506     1.54 (0.67--3.54)    0.311
                                                                                  *P* for trend                                                                                                                      0.003                                                                                                                0.004                          0.323                        0.222                        0.299                          0.171
  BMI^[f](#tfn17-ir-2018-00072){ref-type="table-fn"}^                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                  Quartile I                            1 (Reference)                                                                                                                                                                                 1 (Reference)                 1 (Reference)                1 (Reference)                1 (Reference)                  1 (Reference)        
                                                                                  Quartile II                           2.10 (1.20--3.68)                                                                            0.010                                                                                            2.24 (1.26--4.01)   0.006     2.51 (0.96--6.55)    0.060   2.45 (0.88--6.80)    0.086   1.97 (1.00--3.86)    0.049     2.28 (1.06--4.91)    0.035
                                                                                  Quartile III                          1.48 (0.85--2.59)                                                                            0.169                                                                                            1.56 (0.88--2.78)   0.131     2.25 (0.88--5.75)    0.092   2.01 (0.74--5.46)    0.173   1.58 (0.81--3.07)    0.183     1.62 (0.77--3.44)    0.206
                                                                                  Quartile IV                           3.19 (1.77--5.55)                                                                            \<0.001                                                                                          3.01 (1.67--5.43)   \<0.001   2.67 (0.99--7.45)    0.054   2.34 (0.82--6.70)    0.112   2.47 (1.24--4.94)    0.010     2.34 (1.07--5.09)    0.033
                                                                                  *P* for trend                                                                                                                      0.001                                                                                                                0.001                          0.066                        0.148                        0.023                          0.068
  WC^[g](#tfn18-ir-2018-00072){ref-type="table-fn"}^                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                  Quartile I                            1 (Reference)                                                                                                                                                                                 1 (Reference)                 1 (Reference)                1 (Reference)                1 (Reference)                  1 (Reference)        
                                                                                  Quartile II                           1.77 (1.00--3.12)                                                                            0.049                                                                                            1.81 (1.01--3.25)   0.047     1.85 (0.80--4.29)    0.153   1.89 (0.75--4.72)    0.176   1.50 (0.76--2.96)    0.239     1.59 (0.73--3.44)    0.240
                                                                                  Quartile III                          1.35 (0.77--2.37)                                                                            0.290                                                                                            1.32 (0.74--2.36)   0.344     0.86 (0.34--2.21)    0.759   0.74 (0.27--2.02)    0.553   1.49 (0.78--2.84)    0.230     1.59 (0.76--3.34)    0.216
                                                                                  Quartile IV                           2.25 (1.29--3.94)                                                                            0.004                                                                                            2.20 (1.23--3.94)   0.008     1.09 (0.42--2.82)    0.860   0.85 (0.30--2.39)    0.757   1.45 (0.73--2.89)    0.288     1.23 (0.56--2.69)    0.609
                                                                                  *P* for trend                                                                                                                      0.015                                                                                                                0.027                          0.767                        0.398                        0.284                          0.547
  Plasma fasting glucose level^[h](#tfn19-ir-2018-00072){ref-type="table-fn"}^                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                  Quartile I                            1 (Reference)                                                                                                                                                                                 1 (Reference)                 1 (Reference)                1 (Reference)                1 (Reference)                  1 (Reference)        
                                                                                  Quartile II                           1.33 (0.79--2.25)                                                                            0.280                                                                                            1.34 (0.77--2.32)   0.305     3.32 (1.10--10.00)   0.033   2.28 (0.72--7.24)    0.162   1.58 (0.71--3.52)    0.261     1.04 (0.43--2.51)    0.925
                                                                                  Quartile III                          1.55 (0.90--2.64)                                                                            0.111                                                                                            1.57 (0.90--2.76)   0.115     5.56 (1.92--16.14)   0.002   3.92 (1.25--12.23)   0.019   3.04 (1.44--6.44)    0.004     2.32 (0.99--5.46)    0.054
                                                                                  Quartile IV                           1.79 (1.01--3.19)                                                                            0.048                                                                                            1.82 (0.98--3.36)   0.058     5.40 (1.76--16.61)   0.003   3.20 (0.94--10.87)   0.063   7.88 (3.81--16.27)   \<0.001   4.84 (2.11--11.10)   \<0.001
                                                                                  *P* for trend                                                                                                                      0.034                                                                                                                0.040                          0.001                        0.024                        \<0.001                        0.001
  Serum total cholesterol level^[i](#tfn20-ir-2018-00072){ref-type="table-fn"}^                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                  Quartile I                            1 (Reference)                                                                                                                                                                                 1 (Reference)                 1 (Reference)                1 (Reference)                1 (Reference)                  1 (Reference)        
                                                                                  Quartile II                           1.51 (0.80--2.84)                                                                            0.203                                                                                            1.41 (0.74--2.72)   0.298     0.61 (0.27--1.41)    0.248   0.59 (0.23--1.49)    0.262   0.39 (0.21--0.73)    0.003     0.40 (0.19--0.82)    0.013
                                                                                  Quartile III                          1.49 (0.80--2.75)                                                                            0.208                                                                                            1.46 (0.77--2.76)   0.244     0.45 (0.19--1.05)    0.066   0.36 (0.14--0.95)    0.039   0.15 (0.07--0.32)    \<0.001   0.16 (0.07--0.37)    \<0.001
                                                                                  Quartile IV                           2.04 (1.11--3.76)                                                                            0.022                                                                                            1.78 (0.94--3.36)   0.075     0.23 (0.08--0.67)    0.007   0.17 (0.05--0.55)    0.003   0.15 (0.71--0.33)    \<0.001   0.13 (0.05--0.29)    \<0.001
                                                                                  *P* for trend                                                                                                                      0.031                                                                                                                0.092                          0.004                        0.002                        \<0.001                        \<0.001

Stage I colorectal cancers.

Stages II-IV colorectal cancers.

Unadjusetd model.

Adjusted for gender, age, smoking, education, and the family history of colorectal cancer.

Quartile I represents M\<63.5 kg and F\<51.9 kg; quartile II represents M 63.5--70.5 kg, F 51.9--57.2 kg; quartile III represents M 70.5--76.2 kg, F 57.2--63.8 kg; quartile IV represents M≥76.2 kg, F≥63.8 kg.

Quartile I represents M\<22.7 kg/m^2^ and F\<21.1 kg/m^2^; quartile II represents M 22.7--24.6 kg/m^2^, F 21.1--23.1 kg/m^2^; quartile III represents M 24.6--25.9 kg/m^2^, F 23.1--25.4 kg/m^2^; quartile IV represents M≥25.9 kg/m^2^, F≥25.4 kg/m^2^.

Quartile I represents M\<79.8 cm and F\<76.0 cm; quartile II represents M 79.8--84.6 cm, F 76.0--80.6 cm; quartile III represents M 84.6--89.2 cm, F 80.6--86.3 cm; quartile IV represents M≥89.2 cm, F≥86.3 cm.

Quartile I represents M\<87 mg/dL and F\<84 mg/dL; quartile II represents M 87--95 mg/dL F 84--92 mg/dL; quartile III represents M 95--108 mg/dL, F 92--100.5 mg/dL; quartile IV represents M≥108 mg/dL, F≥100.5 mg/dL.

Quartile I represents M\<168.0 mg/dL and F\<173.5 mg/dL; quartile II represents M 168.0--194.5 mg/dL, F 173.5--195.0 mg/dL; quartile III represents M 194.5--219.3 mg/dL, F 195.0--220.5 mg/dL; quartile IV represents M≥219.3 mg/dL, F≥220.5 mg/dL.

CRC, colorectal cancer; aOR, adjusted OR; WC, waist circumference; M, male; F, female.

Differences were considered significant when *P*-values were \<0.05.

###### 

Comparison of Adipose Tissue Area by the Different Time Points of the CT Scan in the Same Patients with CRC (n=42)

  Stage                       Timing of CT scan   *P*-value^[a](#tfn21-ir-2018-00072){ref-type="table-fn"}^   
  --------------------------- ------------------- ----------------------------------------------------------- -------------
  Early-stage CRC (n=17)                                                                                      
   VAT area (V, cm^2^)        137.0±62.2          121.3±74.3                                                  0.081
   SAT area (S, cm^2^)        130.9±55.7          131.7±66.0                                                  0.888
   Total fat area (cm^2^)     267.9±84.6          253.0±109.3                                                 0.252
   V/(V+S), %                 50.7±13.3           46.6±15.0                                                   **0.018**
  Advanced-stage CRC (n=25)                                                                                   
   VAT area (V, cm^2^)        149.0±70.6          130.7±59.8                                                  **0.034**
   SAT area (S, cm^2^)        151.3±47.7          131.1±44.9                                                  **\<0.001**
   Total fat area (cm^2^)     300.3±75.1          261.8±82.3                                                  **\<0.001**
   V/(V+S), %                 53.4±27.1           49.3±13.0                                                   0.414

*P*-values were calculated using paired *t*-test.

CRC, colorectal cancer; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue; V/(V+S), visceral adipose tissue area/(\[visceral adipose tissue area\]+\[subcutaneous adipose tissue area\]).

Differences were considered significant when *P*-values were \<0.05.
